Rakovina Therapeutics Inc Market Cap ($2.37 Million)
Market Cap & Net Worth: Rakovina Therapeutics Inc (RKV)
Rakovina Therapeutics Inc market cap. Rakovina Therapeutics Inc (V:RKV) has a market capitalization of $2.37 Million (CA$3.28 Million) as of November 4, 2026. Listed on the V stock exchange, this Canada-based company holds position #29827 globally and #1432 in its home market, demonstrating a -8.82% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Rakovina Therapeutics Inc's stock price CA$0.16 by its total outstanding shares 21148039 (21.15 Million). Also see RKV cash flow metrics for how efficiently the company converts equity into cash flow.
Rakovina Therapeutics Inc Market Cap History (2021–2026)
Rakovina Therapeutics Inc market cap history from 2021 to 2026. Data shows change from $3.37 Million to $2.37 Million (-8.19% CAGR). Check today's stock price for Rakovina Therapeutics Inc for real-time trading data and today's change.
Rakovina Therapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Rakovina Therapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Rakovina Therapeutics Inc growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of RKV by Market Capitalization
Companies near Rakovina Therapeutics Inc in the global market cap rankings as of November 4, 2026. Also see Rakovina Therapeutics Inc balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Rakovina Therapeutics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $553.15 |
| #372 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $961.26 |
| #411 | CSL Ltd | AU:CSL | $69.05 Billion | AU$201.16 |
| #497 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $220.83 |
Market Capitalization of Rakovina Therapeutics Inc (2021–2026)
Market capitalization of Rakovina Therapeutics Inc from 2021 to today. Between 2021 and today, Rakovina Therapeutics Inc's market cap moved from $3.37 Million to $ 2.37 Million, with a yearly change of -8.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$2.37 Million | +55.00% |
| 2025 | CA$1.53 Million | -47.37% |
| 2024 | CA$2.91 Million | +123.53% |
| 2023 | CA$1.30 Million | -52.78% |
| 2022 | CA$2.75 Million | -18.18% |
| 2021 | CA$3.37 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Rakovina Therapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.37 Million USD |
| MoneyControl | $2.37 Million USD |
| MarketWatch | $2.37 Million USD |
| marketcap.company | $2.37 Million USD |
| Reuters | $2.37 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Rakovina Therapeutics Inc
Rakovina Therapeutics Inc., a biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets. The company's preclinical product pipeline include kt-2000AI, an poly(ADP)-ribose polymerase (PARP) brain penetrant cancer therapy; kt-3000, a bi-functional small-molecule drug candidate; kt-3283 series … Read more